BEIJING, Nov. 27, 2025 (GLOBE NEWSWIRE) -- InnoCare Pharma (HKEX: 9969; SSE: 688428), a leading biopharmaceutical company focusing on the…
If approved, lecanemab would be the first and only anti-amyloid treatment in Japan to offer an at-home injection from the…
Bringing Cholesterol-Lowering Injections to U.K. Community PharmaciesVANCOUVER, British Columbia, Nov. 27, 2025 (GLOBE NEWSWIRE) -- AVRICORE HEALTH INC. (TSXV: AVCR)…
Nyxoah to Participate in the Piper Sandler 37th Annual Healthcare Conference Mont-Saint-Guibert, Belgium – 27 November, 2025, 10:05pm CET /…
The pioneer method combines the nitrosation assay procedure (NAP) with 15N-enriched nitrosating reagents and 15N NMR spectroscopy for a safer…
Lille (France), Cambridge (Massachusetts, United States), Zurich (Switzerland), November 27, 2025 - GENFIT (Euronext: GNFT), a biopharmaceutical company dedicated to…
New name reflects company’s transformation as it advances toward the final phase of Lybrido™’s clinical development The Arletta butterfly symbolism…
TORONTO, Nov. 27, 2025 (GLOBE NEWSWIRE) -- A new report prepared by Deloitte Canada and commissioned by GS1 Canada finds…
Recognizes the company’s continued investment and expansion of cell therapy manufacturing and R&D operations in Ghent, reinforcing Flanders’ position as…
PALO ALTO, Calif., Nov. 28, 2025 /PRNewswire/ -- DentScribe.ai today announced a major supportability update that brings self-service diagnostics, instant…